IL91306A - Tissue plasminogen variant having amino acid substitution in the protease domain having improved zymogenic or fibrin specific properties - Google Patents
Tissue plasminogen variant having amino acid substitution in the protease domain having improved zymogenic or fibrin specific propertiesInfo
- Publication number
- IL91306A IL91306A IL9130689A IL9130689A IL91306A IL 91306 A IL91306 A IL 91306A IL 9130689 A IL9130689 A IL 9130689A IL 9130689 A IL9130689 A IL 9130689A IL 91306 A IL91306 A IL 91306A
- Authority
- IL
- Israel
- Prior art keywords
- amino acid
- zymogenic
- tissue plasminogen
- protease domain
- zymogens
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL111767A IL111767A (en) | 1988-09-02 | 1989-08-14 | Method for identifying improved activity tissue plasminogen activator variants with substituted amino acid residue in the protease domain |
IL109735A IL109735A (en) | 1988-09-02 | 1989-08-14 | Tissue plasminogen activator variants having zymogenic properties having amino acid insertions after position 304 or 305 or at least one residue deletion at positions 297 to 305 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24085688A | 1988-09-02 | 1988-09-02 | |
US07/384,608 US5108901A (en) | 1988-09-02 | 1989-07-24 | Tissue plasminogen activator having zymogenic or fibrin specific properties |
Publications (2)
Publication Number | Publication Date |
---|---|
IL91306A0 IL91306A0 (en) | 1990-03-19 |
IL91306A true IL91306A (en) | 1997-08-14 |
Family
ID=26933781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9130689A IL91306A (en) | 1988-09-02 | 1989-08-14 | Tissue plasminogen variant having amino acid substitution in the protease domain having improved zymogenic or fibrin specific properties |
Country Status (18)
Country | Link |
---|---|
US (1) | US5108901A (ja) |
EP (1) | EP0457758B1 (ja) |
JP (1) | JP2794028B2 (ja) |
KR (1) | KR0148575B1 (ja) |
AT (1) | ATE124452T1 (ja) |
AU (1) | AU626323B2 (ja) |
CA (1) | CA1341484C (ja) |
DE (1) | DE68923298T2 (ja) |
DK (1) | DK175958B1 (ja) |
ES (1) | ES2018729A6 (ja) |
FI (1) | FI109359B (ja) |
HK (1) | HK1007334A1 (ja) |
HU (1) | HU213922B (ja) |
IE (1) | IE67508B1 (ja) |
IL (1) | IL91306A (ja) |
NO (1) | NO310778B1 (ja) |
NZ (1) | NZ230509A (ja) |
WO (1) | WO1990002798A1 (ja) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736134A (en) * | 1985-04-22 | 1998-04-07 | Genentech, In.C | Tissue plasminogen activator variants |
US5756093A (en) * | 1985-04-22 | 1998-05-26 | Genentech, Inc. | Tissue plasminogen activator variants |
GB8815135D0 (en) * | 1988-06-24 | 1988-08-03 | British Bio Technology | Proteins & nucleic acids |
DK395288D0 (da) * | 1988-07-15 | 1988-07-15 | Novo Industri As | Proteiner |
US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
US5156969A (en) * | 1988-09-02 | 1992-10-20 | Genentech Inc. | Tissue plasminogen activator variant with deletion of amino acids 466-470 having fibrin specific properties |
US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
US5866413A (en) * | 1989-03-06 | 1999-02-02 | Board Of Regents Of The University Of Texas System | Pai-1 mutants |
CA2047702C (en) * | 1989-03-06 | 2000-10-24 | Joseph F. Sambrook | Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression |
US5550042A (en) * | 1989-03-06 | 1996-08-27 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same |
US5304482A (en) * | 1989-03-06 | 1994-04-19 | The Board Of Regents Of The University Of Texas System | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
AU664469B2 (en) * | 1992-06-03 | 1995-11-16 | Genentech Inc. | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
US5472692A (en) * | 1993-07-02 | 1995-12-05 | New England Deaconess Hospital Corporation | Pro-urokinase mutants |
US5877016A (en) | 1994-03-18 | 1999-03-02 | Genentech, Inc. | Human trk receptors and neurotrophic factor inhibitors |
US5656427A (en) * | 1994-08-29 | 1997-08-12 | Gen-Probe Incorporated | Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid |
US5798448A (en) * | 1994-10-27 | 1998-08-25 | Genentech, Inc. | AL-1 neurotrophic factor antibodies |
ZA966663B (en) | 1995-08-17 | 1998-02-06 | Genentech Inc | Traf Inhibitors. |
US6610296B2 (en) | 1995-10-26 | 2003-08-26 | Genentech, Inc. | Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin |
AU735519B2 (en) * | 1996-11-12 | 2001-07-12 | Scripps Research Institute, The | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
US6706504B1 (en) | 1996-11-12 | 2004-03-16 | The Scripps Research Institute | Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
US20030113271A1 (en) * | 1997-01-29 | 2003-06-19 | University Technology Corporation | Formulations for pulmonary delivery |
US20040241645A1 (en) * | 1997-01-31 | 2004-12-02 | Genentech, Inc. | O-fucosyltransferase |
DK0942992T3 (da) | 1997-01-31 | 2007-07-02 | Genentech Inc | O-fucosyltransferase |
WO1999009184A1 (de) * | 1997-08-13 | 1999-02-25 | Roche Diagnostics Gmbh | Plasminogenaktivator mit verbesserter zymogenität und verminderter fibrinbindung |
WO1999009185A1 (de) * | 1997-08-13 | 1999-02-25 | Roche Diagnostics Gmbh | Plasminogenaktivator mit verbesserter zymogenität |
KR100408844B1 (ko) * | 2000-07-29 | 2003-12-06 | 한국산업기술평가원 | 동물세포 발현벡터 |
US20060104969A1 (en) * | 2004-08-16 | 2006-05-18 | Massachusetts Institute Of Technology | Compositions and methods for enhancing structural and functional nervous system reorganization and recovery |
EP2012815A4 (en) * | 2006-04-14 | 2009-12-09 | Massachusetts Inst Technology | IDENTIFICATION AND MODULATION OF MOLECULAR PATHWAYS THAT INDUCE THE PLASTICITY OF THE NERVOUS SYSTEM |
JP2009544325A (ja) * | 2006-07-27 | 2009-12-17 | セントカー・インコーポレーテツド | Bmp−7変異体組成物、方法および使用 |
US10220008B2 (en) | 2013-08-14 | 2019-03-05 | Stc.Unm | Treatment and prevention of stroke and other neurological disorders |
CA2966332C (en) | 2014-11-03 | 2024-04-16 | Thrombolytic Science, Llc | Methods and compositions for safe and effective thrombolysis |
WO2018232305A1 (en) | 2017-06-16 | 2018-12-20 | Thrombolytic Science, Llc | Methods and compositions for thrombolysis |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0125269A1 (en) * | 1982-11-11 | 1984-11-21 | Beecham Group Plc | Pharmaceutically active compounds |
EP0112122B1 (en) * | 1982-12-14 | 1991-08-28 | South African Inventions Development Corporation | Plasminogen activator |
US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
EP0201153A3 (en) * | 1985-02-09 | 1987-10-07 | Beecham Group Plc | Modified enzyme and process for its preparation |
DE3682104D1 (de) * | 1985-04-22 | 1991-11-28 | Genentech Inc | Plasminogenaktivator-mutante des menschlichen gewebes, verfahren und zwischenprodukte dafuer und diese mutante verwendende zusammensetzungen. |
GB8528321D0 (en) * | 1985-11-18 | 1985-12-24 | Ciba Geigy Ag | Modified fibrinolytic agents |
EP0227462B1 (en) * | 1985-12-23 | 1992-04-01 | Chiron Corporation | Novel peptide plasminogen activators |
DK43387A (da) * | 1986-01-29 | 1987-07-30 | Beecham Group Plc | Fibrinolytisk enzym |
DE3789664T3 (de) * | 1986-01-31 | 2004-09-16 | Genetics Institute, LLC, Cambridge | Neue thrombolytische proteine. |
IE81073B1 (en) * | 1986-03-18 | 2000-01-12 | Genentech Inc | Modified human tissue-type plasminogen activator and its preparation |
PT84589B (en) * | 1986-04-02 | 1989-05-09 | Beecham Group Plc | Process for preparing a fibrinolytic enzyme |
DK345087A (da) * | 1986-07-11 | 1988-01-12 | Novo Industri As | Modificeret vaevsplasminogenaktivator |
WO1988005081A2 (en) * | 1986-12-30 | 1988-07-14 | Cetus Corporation | Novel plasminogen activator |
GB8705377D0 (en) * | 1987-03-07 | 1987-04-08 | Beecham Group Plc | Compounds |
NO882226L (no) * | 1987-05-22 | 1988-11-23 | Zymogenetics Inc | Fibrinolytiske proteiner. |
DE3851259T2 (de) * | 1987-06-04 | 1994-12-15 | Eisai Co Ltd | Mutierter t-PA mit Kringle-Ersatz. |
DK302388A (da) * | 1987-06-04 | 1989-02-03 | Zymogenetics Inc | T-pa analoger med dodificeret vaekstfaktordomaene |
SE8702562L (sv) * | 1987-06-18 | 1988-12-19 | Kabigen Ab | Nya fibrinolytiska enzymer |
WO1988010119A1 (en) * | 1987-06-22 | 1988-12-29 | Genetics Institute, Inc. | Novel thrombolytic proteins |
EP0394261A4 (en) * | 1987-07-06 | 1991-09-11 | Genetics Institute, Inc. | Novel thrombolytic proteins |
AU1893988A (en) * | 1987-07-13 | 1989-01-19 | Collaborative Research Inc. | Nonglycosylated plasminogen activator and method of preparation |
DK395288D0 (da) * | 1988-07-15 | 1988-07-15 | Novo Industri As | Proteiner |
-
1989
- 1989-07-24 US US07/384,608 patent/US5108901A/en not_active Expired - Lifetime
- 1989-08-14 IL IL9130689A patent/IL91306A/xx active IP Right Grant
- 1989-08-17 IE IE265089A patent/IE67508B1/en not_active IP Right Cessation
- 1989-08-29 KR KR1019900700927A patent/KR0148575B1/ko not_active IP Right Cessation
- 1989-08-29 AU AU41946/89A patent/AU626323B2/en not_active Expired
- 1989-08-29 AT AT89909997T patent/ATE124452T1/de not_active IP Right Cessation
- 1989-08-29 WO PCT/US1989/003755 patent/WO1990002798A1/en active IP Right Grant
- 1989-08-29 HU HU896005A patent/HU213922B/hu unknown
- 1989-08-29 DE DE68923298T patent/DE68923298T2/de not_active Expired - Lifetime
- 1989-08-29 JP JP1509288A patent/JP2794028B2/ja not_active Expired - Lifetime
- 1989-08-29 EP EP89909997A patent/EP0457758B1/en not_active Expired - Lifetime
- 1989-08-31 NZ NZ230509A patent/NZ230509A/en unknown
- 1989-09-01 CA CA000610241A patent/CA1341484C/en not_active Expired - Lifetime
- 1989-09-01 ES ES8903004A patent/ES2018729A6/es not_active Expired - Fee Related
-
1991
- 1991-02-28 NO NO19910811A patent/NO310778B1/no not_active IP Right Cessation
- 1991-03-01 FI FI911049A patent/FI109359B/fi active
- 1991-03-01 DK DK199100369A patent/DK175958B1/da not_active IP Right Cessation
-
1998
- 1998-06-25 HK HK98106560A patent/HK1007334A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5108901A (en) | 1992-04-28 |
DK175958B1 (da) | 2005-08-29 |
FI109359B (fi) | 2002-07-15 |
EP0457758A1 (en) | 1991-11-27 |
KR0148575B1 (ko) | 1998-10-15 |
IE67508B1 (en) | 1996-04-03 |
DE68923298D1 (de) | 1995-08-03 |
DK36991A (da) | 1991-05-02 |
KR900702019A (ko) | 1990-12-05 |
DK36991D0 (da) | 1991-03-01 |
IL91306A0 (en) | 1990-03-19 |
IE892650L (en) | 1990-03-02 |
EP0457758B1 (en) | 1995-06-28 |
NZ230509A (en) | 1991-06-25 |
FI911049A0 (fi) | 1991-03-01 |
HUT58812A (en) | 1992-03-30 |
HU213922B (en) | 1997-11-28 |
DE68923298T2 (de) | 1996-01-11 |
JP2794028B2 (ja) | 1998-09-03 |
ATE124452T1 (de) | 1995-07-15 |
ES2018729A6 (es) | 1991-05-01 |
NO310778B1 (no) | 2001-08-27 |
NO910811L (no) | 1991-02-28 |
JPH04500157A (ja) | 1992-01-16 |
CA1341484C (en) | 2005-05-24 |
NO910811D0 (no) | 1991-02-28 |
AU626323B2 (en) | 1992-07-30 |
HK1007334A1 (en) | 1999-04-09 |
WO1990002798A1 (en) | 1990-03-22 |
AU4194689A (en) | 1990-04-02 |
HU896005D0 (en) | 1991-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL91306A (en) | Tissue plasminogen variant having amino acid substitution in the protease domain having improved zymogenic or fibrin specific properties | |
Kini | Serine proteases affecting blood coagulation and fibrinolysis from snake venoms | |
Joseph et al. | Amino acid sequence of trocarin, a prothrombin activator from Tropidechis carinatus venom: its structural similarity to coagulation factor Xa | |
EP0473689B1 (en) | Thrombus-targeted complexes of plasminogen activator and fibrin fragments | |
Matsuda et al. | A simple, large scale method for preparation of plasminogen-free fibrinogen | |
Etscheid et al. | Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism | |
Paoni et al. | Making tissue-type plasminogen activator more fibrin specific | |
Siigur et al. | The direct actinc α-fibrin (ogen) olytic enzymes from snake venoms | |
DK0517756T3 (da) | Vævs-plasminogenaktivator med fibrinspecifikke egenskaber | |
Gardell | The search for the ideal thrombolytic agent: maximize the benefit and minimize the risk | |
Bachmann | Fibrinolytic agents | |
Agnelli et al. | Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits | |
Bode et al. | New developments in thrombolytic therapy | |
Deguchi et al. | Plasminogen activation by tissue plasminogen activator in the presence of platelets | |
DE69113049D1 (de) | Varianten des gewebeplasminogenaktivators mit vermindertem abbau. | |
Credo et al. | Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase | |
MXPA06002756A (es) | Activadores de plasminogeno que tienen capacidad reducida para union a lisina. | |
ATE114170T1 (de) | Substitutionsvariante des gewebeplasminogenaktivators. | |
Loscalzo | Fibrinolytic therapy | |
ATE145669T1 (de) | T-pa substitutionsvarianten mit verbesserter fibrinspezifität | |
Anderson et al. | Tissue plasminogen activator having zymogenic or fibrin specific properties | |
Runge | New horizons in the treatment of coronary artery thrombosis | |
Siigur et al. | Polypeptides and proteins active in the coagulation process | |
Anderson et al. | Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties | |
HUT65411A (en) | Combined preparation with thrombolytic action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |